Teva enters market of milk substitutes for babies

The company announced at a press conference Monday that it had come to an agreement with Dutch-based medical nutrition company Nutricia.

June 27, 2011 22:55
1 minute read.
Teva enters market of milk substitutes for babies

Teva. (photo credit: Ariel Jerozolimski)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

As the war over cottage cheese prices continues to dominate the headlines, Teva Pharmaceutical Industries is also preparing to enter the world of dairy – by taking on the two Israeli companies already offering milk substitutes for infants.

The company announced at a press conference Monday that it had come to an agreement with Dutch-based medical nutrition company Nutricia to provide milk substitutes for infants in Israel. Nutricia, a specialized unit of French food products multinational Danone, is one of the European leaders in milk alternatives.

Be the first to know - Join our Facebook page.

Teva Israel CEO Ron Meron said, “We chose to work with Nutricia because of its vast international experience, the quality and variety of its products and the scope of its investment in research.”

Nutricia Export CEO Hans Van Der Wulp, who joined Meron for the announcement, said the two companies were responsible “first and foremost to parents and their children.” “We are committed to product safety, through our long tradition of R&D alongside the policy of ‘farm to table,’ which we personify with comprehensive supervision along the whole chain, from production to packaging, to delivery and distribution.”

Milk substitutes are a big business in Israel, with information provided to the press by Teva showing that annual sales totaled around NIS 500 million in the 12 months ending May – showing annual growth of around six percent.

The market is currently dominated by two companies – Materna and Similac.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection